Previous close | 0.2300 |
Open | 0.2100 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 62.50 |
Expiry date | 2025-01-17 |
Day's range | 0.2100 - 0.2300 |
Contract range | N/A |
Volume | |
Open interest | 1.84k |
PRINCETON, N.J., May 21, 2024--Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivo and hyaluronidase)
Key Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price might be vulnerable...
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.